4.7 Letter

Vitamin D deficiency aggravates COVID-19: discussion of the evidence

期刊

出版社

TAYLOR & FRANCIS INC
DOI: 10.1080/10408398.2021.1951653

关键词

Vitamin D; COVID-19; SarCov-2; meta-analysis

向作者/读者索取更多资源

This article discusses the association between vitamin D deficiency and COVID-19, providing updated statistics. The study found that individuals with vitamin D deficiency had a higher chance of hospitalization and there was a certain relationship between vitamin D deficiency and mortality in COVID-19 patients. Vitamin D is associated with the severity of COVID-19.
We discuss the quality of the article evidence on the association between vitamin D deficiency and COVID-19, as well as updating the statistics in response to the letter to the editor regarding the same paper. Our review included 22 studies with data available in 23 articles. Using crude OR data, we observed that the chance of hospitalization was 2.16 (CI 95% = 1.42 - 2.89;) for vitamin-deficient individuals compared to non-deficient ones. However, when using the adjusted OR, it was possible to obtain a chance of 1.78 (CI 95% = 1.36-2.20). For the outcome vitamin D deficiency and death in patients with COVID-19 infection the crude association value was 1.38 (OR =1.38; CI 95% = 1.08 - 1.68) and the adjusted OR with the two studies was 1.08 (CI 95% = 0.82- 1.34). This new analyzes don't substantially alter our results. Vitamin D remains associated with severity COVID-19.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据